Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Holding DE:6Y4?
Track your performance easily
6Y4 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.56 - €1.95
Previous Close€0.62
Volume0.00
Average Volume (3M)N/A
Market Cap
€157.53M
Enterprise Value€134.90M
Total Cash (Recent Filing)kr261.74M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.68
Next Earnings
Feb 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 16, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)11610.75
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
― Other Institutional Investors
99.93% Public Companies and
Individual Investors
6Y4 FAQ
What was Vicore Pharma Holding AB’s price range in the past 12 months?
Vicore Pharma Holding AB lowest stock price was €0.56 and its highest was €1.95 in the past 12 months.
What is Vicore Pharma Holding AB’s market cap?
Currently, no data Available
When is Vicore Pharma Holding AB’s upcoming earnings report date?
Vicore Pharma Holding AB’s upcoming earnings report date is Feb 27, 2025 which is in 97 days.
How were Vicore Pharma Holding AB’s earnings last quarter?
Vicore Pharma Holding AB released its earnings results on Nov 05, 2024. The company reported -€0.046 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.046.
Is Vicore Pharma Holding AB overvalued?
According to Wall Street analysts Vicore Pharma Holding AB’s price is currently Overvalued.
Does Vicore Pharma Holding AB pay dividends?
Vicore Pharma Holding AB pays a Notavailable dividend of €0.28 which represents an annual dividend yield of N/A. See more information on Vicore Pharma Holding AB dividends here
What is Vicore Pharma Holding AB’s EPS estimate?
Vicore Pharma Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vicore Pharma Holding AB have?
Vicore Pharma Holding AB has 234,579,120 shares outstanding.
What happened to Vicore Pharma Holding AB’s price movement after its last earnings report?
Vicore Pharma Holding AB reported an EPS of -€0.046 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.563%.
Which hedge fund is a major shareholder of Vicore Pharma Holding AB?
Currently, no hedge funds are holding shares in DE:6Y4
---
Vicore Pharma Holding AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.60%
12-Months-Change
Fundamentals
Return on Equity
-41.32%
Trailing 12-Months
Asset Growth
-32.46%
Trailing 12-Months
Company Description
Vicore Pharma Holding AB
Vicore Pharma Holding AB is a drug development company. The company's through is a subsidiary is developing a new type of pharmaceutical compound, known as AT2R agonists, to stimulate the AT2 receptor within the Renin-Angiotensin system. Its drug candidate, C21, is the first small molecule compound in its class.
---
Technical Analysis
---